/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

Madrigal Pharmaceuticals, Inc.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$574.27 0.0118(1.18%) MDGL at 04 Dec 2025 04:38 PM Biotechnology
Lowest Today 576.01
Highest Today 591.93
Today’s Open 579.55
Prev. Close 573.15
52 Week High 605.00
52 Week Low 265.00
Day’s Range: Low 576.01 High 591.93
52-Week Range: Low 265.00 High 605.00
1 day return -
1 Week return -2.94
1 month return +30.24
3 month return +34.53
6 month return +106.91
1 year return +81.0
3 year return +697.06
5 year return +389.18
10 year return -

Institutional Holdings

HHG PLC 9.83

Paulson & Company Inc 9.37

RTW INVESTMENTS, LLC 8.94

Baker Bros Advisors LP 8.87

Vanguard Group Inc 8.42

venBio Select Advisor LLC 8.41

BlackRock Inc 6.45

State Street Corp 3.10

Janus Concentrated Growth CF 2.71

Janus Henderson Forty S 2.71

Vanguard Total Stock Mkt Idx Inv 2.69

T. Rowe Price Associates, Inc. 2.28

UBS Group AG 2.27

Vanguard Small Cap Index 2.06

FMR Inc 2.00

Geode Capital Management, LLC 1.86

iShares Russell 2000 ETF 1.83

Adage Capital Partners Gp LLC 1.69

William Blair Investment Management, LLC 1.57

Janus Henderson Contrarian D 1.37

Janus Henderson US Opportunistic Alpha 1.37

SPDR® S&P Biotech ETF 1.34

Vanguard Small Cap Value Index Inv 1.32

Bank of America Corp 1.24

Morgan Stanley - Brokerage Accounts 1.11

Hood River Capital Management LLC 1.10

Polar Capital Holdings PLC 1.01

Polar Capital Biotech S Inc 1.01

RTW Biotech Opportunities Ord 0.96

Pictet Asset Manangement SA 0.93

Citadel Advisors Llc 0.93

Vanguard Institutional Extnd Mkt Idx Tr 0.84

Janus Henderson Global Life Sciences 0.79

Janus Henderson Global Life Sciences D 0.79

Fidelity Small Cap Index 0.76

US Small-Cap Growth II Equity Comp 0.71

Fidelity Small Cap Growth 0.69

iShares Russell 2000 Growth ETF 0.67

Janus Global Life Science AUSD 0.66

Janus Henderson US SMID Cap Growth MA 0.62

Market Status

Strong Buy: 10

Buy: 3

Hold: 1

Sell: 1

Strong Sell: 0

Fundamentals

Market Cap 13017.05 M

PB Ratio 21.6678

PE Ratio 0.0

Enterprise Value 12396.79 M

Total Assets 1042.25 M

Volume 264717

Company Financials

Annual Revenue FY24:180133000 180.1M, FY23:0 0.0M, FY22:0 0.0M, FY21:37318 0.0M, FY20:21864 0.0M

Annual Profit FY24:173900000 173.9M, FY23:-527000 -0.5M, FY22:null 0.0M, FY21:273000 0.3M, FY20:21864 0.0M

Annual Net worth FY24:-465892000 -465.9M, FY23:-373630000 -373.6M, FY22:-299314000 -299.3M, FY21:-241078000 -241.1M, FY20:-197444000 -197.4M

Quarterly Revenue Q3/2025:287268000 287.3M, Q2/2025:212802000 212.8M, Q1/2025:137250000 137.3M, Q3/2024:62175000 62.2M, Q2/2024:14638000 14.6M

Quarterly Profit Q3/2025:269146000 269.1M, Q2/2025:203360000 203.4M, Q1/2025:132737000 132.7M, Q3/2024:60023000 60.0M, Q2/2024:13735000 13.7M

Quarterly Net worth Q3/2025:-114190000 -114.2M, Q2/2025:-42281000 -42.3M, Q1/2025:-73238000 -73.2M, Q3/2024:-106964000 -107.0M, Q2/2024:-151971000 -152.0M

Fund house & investment objective

Company Information Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Organisation Biotechnology

Employees 528

Industry Biotechnology

CEO Mr. William J. Sibold

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow